6 years of historical data (2019–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
AirSculpt Technologies, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Market Cap | $220M | $299M | $425M | $206M | $956M | — | — |
| Enterprise Value | $317M | $396M | $515M | $304M | $1.0B | — | — |
| P/E Ratio → | -25.14 | — | — | — | — | — | — |
| P/S Ratio | 1.22 | 1.66 | 2.17 | 1.22 | 7.17 | — | — |
| P/B Ratio | 2.56 | 3.78 | 5.06 | 2.91 | 11.45 | — | — |
| P/FCF | — | — | 30.30 | 17.88 | 49.01 | — | — |
| P/OCF | 19.36 | 26.38 | 17.75 | 8.43 | 35.91 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
AirSculpt Technologies, Inc.'s enterprise value stands at 31.4x EBITDA, 37% below its 5-year average of 49.5x. The Healthcare sector median is 14.0x, placing the stock at a 124% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.20 | 2.63 | 1.80 | 7.74 | — | — |
| EV / EBITDA | 31.43 | 39.34 | 26.08 | 86.48 | 46.13 | — | — |
| EV / EBIT | — | — | 54.27 | — | 65.43 | — | — |
| EV / FCF | — | — | 36.67 | 26.38 | 52.86 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
AirSculpt Technologies, Inc. earns an operating margin of -1.0%. Operating margins have expanded from -2.7% to -1.0% over the past 3 years, signaling improving operational efficiency. A negative ROE of -10.1% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 60.4% | 60.4% | 62.2% | 65.5% | 66.6% | 62.6% | 62.4% |
| Operating Margin | -1.0% | -1.0% | 4.8% | -2.7% | 11.8% | 16.0% | 1.6% |
| Net Profit Margin | -4.6% | -4.6% | -2.3% | -8.7% | 7.9% | 12.1% | -5.4% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| ROE | -10.1% | -10.1% | -5.8% | -19.0% | 10.2% | 6.2% | -1.8% |
| ROA | -4.0% | -4.0% | -2.2% | -7.3% | 5.6% | 4.3% | -1.3% |
| ROIC | -0.8% | -0.8% | 4.2% | -2.1% | 7.3% | 4.7% | — |
| ROCE | -1.0% | -1.0% | 5.2% | -2.5% | 8.9% | 6.0% | 0.4% |
Solvency and debt-coverage ratios — lower is generally safer
AirSculpt Technologies, Inc. carries a Debt/EBITDA ratio of 10.4x, which is highly leveraged (234% above the sector average of 3.1x). Net debt stands at $97M ($105M total debt minus $8M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.32 | 1.32 | 1.19 | 1.52 | 1.20 | 0.40 | 0.37 |
| Debt / EBITDA | 10.43 | 10.43 | 5.05 | 30.62 | 4.50 | 3.18 | 8.02 |
| Net Debt / Equity | — | 1.22 | 1.06 | 1.39 | 0.90 | 0.32 | 0.33 |
| Net Debt / EBITDA | 9.61 | 9.61 | 4.53 | 27.88 | 3.36 | 2.51 | 7.11 |
| Debt / FCF | — | — | 6.37 | 8.51 | 3.85 | 3.84 | 80.11 |
| Interest Coverage | -0.29 | -0.29 | 1.46 | -0.67 | 3.23 | 4.09 | 0.23 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.60x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.75x to 0.60x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.60 | 0.60 | 0.79 | 0.75 | 1.79 | 1.22 | 0.79 |
| Quick Ratio | 0.60 | 0.60 | 0.79 | 0.75 | 1.79 | 1.22 | 0.79 |
| Cash Ratio | 0.29 | 0.29 | 0.51 | 0.43 | 1.54 | 1.10 | 0.61 |
| Asset Turnover | — | 0.86 | 0.96 | 0.84 | 0.66 | 0.35 | 0.24 |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 6.18 | 3.62 | 6.12 | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
AirSculpt Technologies, Inc. returns 0.5% to shareholders annually — split between a 0.1% dividend yield and 0.4% buyback yield.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.1% | 0.1% | 0.1% | 11.8% | 7.0% | — | — |
| Payout Ratio | — | — | — | — | 633.6% | 60.9% | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | 3.3% | 5.6% | 2.0% | — | — |
| Buyback Yield | 0.4% | 0.3% | 0.1% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.5% | 0.4% | 0.2% | 11.8% | 7.0% | — | — |
| Shares Outstanding | — | $58M | $57M | $56M | $56M | $56M | $56M |
Compare AIRS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $220M | -25.1 | 31.4 | — | 60.4% | -1.0% | -10.1% | -0.8% | 10.4 | |
| $116M | -5.6 | 7290.5 | 3.1 | 65.3% | -6.9% | -16.8% | -6.8% | 10519.4 | |
| $912M | 10.1 | 7.2 | 10.8 | 78.5% | 23.0% | 13.5% | 13.5% | 0.2 | |
| $6M | -0.6 | — | — | 56.9% | -27.6% | -114.2% | -38.9% | — | |
| $2B | -41.3 | — | — | 69.3% | -18.5% | -133.3% | -42.1% | — | |
| $100B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 | |
| $113B | 35.1 | 20.4 | 26.4 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| $160B | 57.4 | 43.4 | 64.4 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 | |
| $152B | 11.4 | 15.9 | 23.9 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 | |
| $16B | 23.4 | 9.4 | 11.0 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 | |
| $2B | 18.7 | 11.6 | 11.1 | 43.2% | 31.9% | 8.7% | 5.7% | 3.9 | |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 6 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs The Beauty Health Company.
Start ComparisonQuick answers to the most common questions about buying AIRS stock.
AirSculpt Technologies, Inc.'s current P/E ratio is -25.1x. This places it at the 50th percentile of its historical range.
AirSculpt Technologies, Inc.'s current EV/EBITDA is 31.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 49.5x.
AirSculpt Technologies, Inc.'s return on equity (ROE) is -10.1%. The historical average is -3.4%.
Based on historical data, AirSculpt Technologies, Inc. is trading at a P/E of -25.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
AirSculpt Technologies, Inc.'s current dividend yield is 0.12%.
AirSculpt Technologies, Inc. has 60.4% gross margin and -1.0% operating margin.
AirSculpt Technologies, Inc.'s Debt/EBITDA ratio is 10.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.